NCT06589518: To Evaluate the Efficacy and Safety of Tenofovir Alafenamide Conversion in Liver Transplant Patients
- State
- Not started
- Phase
- Phase 2
- People
- 108 planned
- Started
- 1 Mar 2025
- Primary completion
- 31 Mar 2026
- Arms
- Experimental(Tenofovir alafenamide)
- Results
- None posted
- 19 Sep 2024: Trial registered